Royal Society of Chemistry, RSC Medicinal Chemistry, 2(11), p. 164-183, 2020
DOI: 10.1039/c9md00447e
Full text: Unavailable
Pancreatic cancer (PC), with a 5-year survival of <7%, is one of the most fatal of all human cancers. There is an urgent need to develop more effective therapies to move beyond the current dire condition and paucity of PC treatment options.